{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:10:20Z","timestamp":1788826220487,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Joint Project on the Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["2024GXNSFBA010303"],"award-info":[{"award-number":["2024GXNSFBA010303"]}]},{"name":"Joint Project on the Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["2024GXNSFBA010303"],"award-info":[{"award-number":["2024GXNSFBA010303"]}]},{"name":"Joint Project on the Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["2024GXNSFBA010303"],"award-info":[{"award-number":["2024GXNSFBA010303"]}]},{"name":"Joint Project on the Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["2024GXNSFBA010303"],"award-info":[{"award-number":["2024GXNSFBA010303"]}]},{"name":"Joint Project on the Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["2024GXNSFBA010303"],"award-info":[{"award-number":["2024GXNSFBA010303"]}]},{"name":"Joint Project on the Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["2024GXNSFBA010303"],"award-info":[{"award-number":["2024GXNSFBA010303"]}]},{"name":"Joint Project on the Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["2024GXNSFBA010303"],"award-info":[{"award-number":["2024GXNSFBA010303"]}]},{"name":"Joint Project on the Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["2024GXNSFBA010303"],"award-info":[{"award-number":["2024GXNSFBA010303"]}]},{"name":"Joint Project on the Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["2024GXNSFBA010303"],"award-info":[{"award-number":["2024GXNSFBA010303"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10147-026-03084-1","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T17:16:24Z","timestamp":1781370984000},"page":"1678-1695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unveiling VARS1: a key driver of colorectal cancer progression and immune modulation"],"prefix":"10.1007","volume":"31","author":[{"given":"Jiale","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuman","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"3084_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"3084_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"3084_CR3","doi-asserted-by":"publisher","first-page":"110170","DOI":"10.1016\/j.cbi.2022.110170","volume":"368","author":"MR Islam","year":"2022","unstructured":"Islam MR, Akash S, Rahman MM, Nowrin FT, Akter T, Shohag S et al (2022) Colon cancer and colorectal cancer: prevention and treatment by potential natural products. Chem Biol Interact 368:110170. https:\/\/doi.org\/10.1016\/j.cbi.2022.110170","journal-title":"Chem Biol Interact"},{"key":"3084_CR4","doi-asserted-by":"publisher","first-page":"112000","DOI":"10.1016\/j.ejrad.2025.112000","volume":"185","author":"JR Platt","year":"2025","unstructured":"Platt JR, Pennycook S, Muthoo CE, Westwood AC, Frood R, Beggs AD et al (2025) Colon cancer biology and treatment in the era of precision oncology: a primer for Radiologists. Eur J Radiol 185:112000. https:\/\/doi.org\/10.1016\/j.ejrad.2025.112000","journal-title":"Eur J Radiol"},{"key":"3084_CR5","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.7150\/jca.98337","volume":"15","author":"J Song","year":"2024","unstructured":"Song J, Jin Y, Fan S, Wei Y, Dong D, Jia L et al (2024) CDH3 Is an effective serum biomarker of colorectal cancer distant metastasis patients. J Cancer 15:5218\u20135229. https:\/\/doi.org\/10.7150\/jca.98337","journal-title":"J Cancer"},{"key":"3084_CR6","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1261\/rna.071720.119","volume":"26","author":"MA Rubio Gomez","year":"2020","unstructured":"Rubio Gomez MA, Ibba M (2020) Aminoacyl-tRNA synthetases. RNA 26:910\u2013936. https:\/\/doi.org\/10.1261\/rna.071720.119","journal-title":"RNA"},{"key":"3084_CR7","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41556-024-01430-x","volume":"26","author":"Q Wu","year":"2024","unstructured":"Wu Q, Tavazoie SF (2024) Translational control by VARS in melanoma. Nat Cell Biol 26:1023\u20131024. https:\/\/doi.org\/10.1038\/s41556-024-01430-x","journal-title":"Nat Cell Biol"},{"key":"3084_CR8","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.cell.2016.05.046","volume":"165","author":"H Goodarzi","year":"2016","unstructured":"Goodarzi H, Nguyen HCB, Zhang S, Dill BD, Molina H, Tavazoie SF (2016) Modulated expression of specific tRNAs drives gene expression and cancer progression. Cell 165:1416\u20131427. https:\/\/doi.org\/10.1016\/j.cell.2016.05.046","journal-title":"Cell"},{"key":"3084_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41556-022-00856-5","volume":"24","author":"MC Passarelli","year":"2022","unstructured":"Passarelli MC, Pinzaru AM, Asgharian H, Liberti MV, Heissel S, Molina H et al (2022) Leucyl-tRNA synthetase is a tumour suppressor in breast cancer and regulates codon-dependent translation dynamics. Nat Cell Biol 24:307\u2013315. https:\/\/doi.org\/10.1038\/s41556-022-00856-5","journal-title":"Nat Cell Biol"},{"key":"3084_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.neuron.2015.09.048","volume":"88","author":"E Karaca","year":"2015","unstructured":"Karaca E, Harel T, Pehlivan D, Jhangiani SN, Gambin T, Coban Akdemir Z et al (2015) Genes that affect brain structure and function identified by rare variant analyses of mendelian neurologic disease. Neuron 88:499\u2013513. https:\/\/doi.org\/10.1016\/j.neuron.2015.09.048","journal-title":"Neuron"},{"key":"3084_CR11","doi-asserted-by":"publisher","first-page":"795","DOI":"10.11817\/j.issn.1672-7347.2023.220602","volume":"48","author":"R Shi","year":"2023","unstructured":"Shi R, Du W, He Y, Hu J, Yu H, Zhou W et al (2023) High expression of VARS promotes the growth of multiple myeloma cells by causing imbalance in valine metabolism. Zhong Nan Da Xue Xue Bao Yi Xue Ban 48:795\u2013808. https:\/\/doi.org\/10.11817\/j.issn.1672-7347.2023.220602","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"3084_CR12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s12967-022-03686-z","volume":"20","author":"Z Wu","year":"2022","unstructured":"Wu Z, Lei K, Li H, He J, Shi E (2022) Transcriptome-based network analysis related to M2-like tumor-associated macrophage infiltration identified VARS1 as a potential target for improving melanoma immunotherapy efficacy. J Transl Med 20:489. https:\/\/doi.org\/10.1186\/s12967-022-03686-z","journal-title":"J Transl Med"},{"key":"3084_CR13","doi-asserted-by":"publisher","first-page":"R884","DOI":"10.1016\/j.cub.2024.08.029","volume":"34","author":"R Tennakoon","year":"2024","unstructured":"Tennakoon R, Cui H (2024) Aminoacyl-tRNA synthetases. Curr Biol 34:R884\u2013R. https:\/\/doi.org\/10.1016\/j.cub.2024.08.029","journal-title":"Curr Biol"},{"key":"3084_CR14","doi-asserted-by":"publisher","first-page":"21979","DOI":"10.18632\/oncotarget.4273","volume":"6","author":"CW Lee","year":"2015","unstructured":"Lee CW, Chang KP, Chen YY, Liang Y, Hsueh C, Yu JS et al (2015) Overexpressed tryptophanyl-tRNA synthetase, an angiostatic protein, enhances oral cancer cell invasiveness. Oncotarget 6:21979\u201321992. https:\/\/doi.org\/10.18632\/oncotarget.4273","journal-title":"Oncotarget"},{"key":"3084_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12943-024-02206-5","volume":"24","author":"N Herman-Sanchez","year":"2025","unstructured":"Herman-Sanchez N, Del Rio-Moreno M, Ciria R, Sanchez-Frias ME, Fernandez-Barrena MG, Uriarte I et al (2025) Quantitative proteomic analysis unveils a critical role of VARS1 in hepatocellular carcinoma aggressiveness through the modulation of MAGI1 expression. Mol Cancer 24:15. https:\/\/doi.org\/10.1186\/s12943-024-02206-5","journal-title":"Mol Cancer"},{"key":"3084_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1126\/science.aau2753","volume":"367","author":"I Yoon","year":"2020","unstructured":"Yoon I, Nam M, Kim HK, Moon HS, Kim S, Jang J et al (2020) Glucose-dependent control of leucine metabolism by leucyl-tRNA synthetase 1. Science 367:205\u2013210. https:\/\/doi.org\/10.1126\/science.aau2753","journal-title":"Science"},{"key":"3084_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3858\/emm.2008.40.2.229","volume":"40","author":"SH Shin","year":"2008","unstructured":"Shin SH, Kim HS, Jung SH, Xu HD, Jeong YB, Chung YJ (2008) Implication of leucyl-tRNA synthetase 1 (LARS1) over-expression in growth and migration of lung cancer cells detected by siRNA targeted knock-down analysis. Exp Mol Med 40:229\u2013236. https:\/\/doi.org\/10.3858\/emm.2008.40.2.229","journal-title":"Exp Mol Med"},{"key":"3084_CR18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12943-024-02069-w","volume":"23","author":"S Kiri","year":"2024","unstructured":"Kiri S, Ryba T (2024) Cancer, metastasis, and the epigenome. Mol Cancer 23:154. https:\/\/doi.org\/10.1186\/s12943-024-02069-w","journal-title":"Mol Cancer"},{"key":"3084_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15:178\u2013196. https:\/\/doi.org\/10.1038\/nrm3758","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3084_CR20","doi-asserted-by":"publisher","first-page":"102576","DOI":"10.1016\/j.arr.2024.102576","volume":"102","author":"R Thapa","year":"2024","unstructured":"Thapa R, Gupta S, Gupta G, Bhat AA, Smriti, Singla M et al (2024) Epithelial-mesenchymal transition to mitigate age-related progression in lung cancer. Ageing Res Rev 102:102576. https:\/\/doi.org\/10.1016\/j.arr.2024.102576","journal-title":"Ageing Res Rev"},{"key":"3084_CR21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin AE, Giancotti FG, Rustgi AK (2023) Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci 44:222\u2013236. https:\/\/doi.org\/10.1016\/j.tips.2023.01.003","journal-title":"Trends Pharmacol Sci"},{"key":"3084_CR22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","volume":"13","author":"V Mittal","year":"2018","unstructured":"Mittal V (2018) Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol 13:395\u2013412. https:\/\/doi.org\/10.1146\/annurev-pathol-020117-043854","journal-title":"Annu Rev Pathol"},{"key":"3084_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev.genet.40.110405.090412","volume":"44","author":"DF Jarosz","year":"2010","unstructured":"Jarosz DF, Taipale M, Lindquist S (2010) Protein homeostasis and the phenotypic manifestation of genetic diversity: principles and mechanisms. Annu Rev Genet 44:189\u2013216. https:\/\/doi.org\/10.1146\/annurev.genet.40.110405.090412","journal-title":"Annu Rev Genet"},{"key":"3084_CR24","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.2337\/db13-0368","volume":"62","author":"DG Hardie","year":"2013","unstructured":"Hardie DG (2013) AMPK: a target for drugs and natural products with effects on both diabetes and cancer. Diabetes 62:2164\u20132172. https:\/\/doi.org\/10.2337\/db13-0368","journal-title":"Diabetes"},{"key":"3084_CR25","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","volume":"6","author":"R Huang","year":"2021","unstructured":"Huang R, Zhou PK (2021) DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal Transduct Target Ther 6:254. https:\/\/doi.org\/10.1038\/s41392-021-00648-7","journal-title":"Signal Transduct Target Ther"},{"key":"3084_CR26","doi-asserted-by":"publisher","first-page":"1233259","DOI":"10.3389\/fcell.2023.1233259","volume":"11","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang W, Zhang J, Gao S, Xu T, Yin Y (2023) JAK\/STAT signaling in diabetic kidney disease. Front Cell Dev Biol 11:1233259. https:\/\/doi.org\/10.3389\/fcell.2023.1233259","journal-title":"Front Cell Dev Biol"},{"key":"3084_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/bjc.2015.233","volume":"113","author":"SJ Thomas","year":"2015","unstructured":"Thomas SJ, Snowden JA, Zeidler MP, Danson SJ (2015) The role of JAK\/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer 113:365\u2013371. https:\/\/doi.org\/10.1038\/bjc.2015.233","journal-title":"Br J Cancer"},{"key":"3084_CR28","doi-asserted-by":"publisher","unstructured":"Owen KL, Brockwell NK, Parker BS (2019) JAK-STAT signaling: a double-edged sword of immune regulation and cancer progression. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11122002","DOI":"10.3390\/cancers11122002"},{"key":"3084_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc1275","volume":"4","author":"H Yu","year":"2004","unstructured":"Yu H, Jove R (2004) The STATs of cancer\u2013new molecular targets come of age. Nat Rev Cancer 4:97\u2013105. https:\/\/doi.org\/10.1038\/nrc1275","journal-title":"Nat Rev Cancer"},{"key":"3084_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W (2021) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther 6:402. https:\/\/doi.org\/10.1038\/s41392-021-00791-1","journal-title":"Signal Transduct Target Ther"},{"key":"3084_CR31","doi-asserted-by":"publisher","first-page":"1507621","DOI":"10.3389\/fcell.2024.1507621","volume":"12","author":"P Li","year":"2024","unstructured":"Li P, Huang D (2024) Targeting the JAK-STAT pathway in colorectal cancer: mechanisms, clinical implications, and therapeutic potential. Front Cell Dev Biol 12:1507621. https:\/\/doi.org\/10.3389\/fcell.2024.1507621","journal-title":"Front Cell Dev Biol"},{"key":"3084_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10090341","author":"S Leon-Cabrera","year":"2018","unstructured":"Leon-Cabrera S, Vazquez-Sandoval A, Molina-Guzman E, Delgado-Ramirez Y, Delgado-Buenrostro NL, Callejas BE et al (2018) Deficiency in STAT1 signaling predisposes gut inflammation and prompts colorectal cancer development. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers10090341","journal-title":"Cancers (Basel)"},{"key":"3084_CR33","doi-asserted-by":"publisher","unstructured":"Li T, Luo C, Liu Z, Li J, Han M, Zhang R et al (2024) Nicotinamide mononucleotide protects STAT1 from oxidative stress-induced degradation to prevent colorectal tumorigenesis. MedComm 5:e70006. https:\/\/doi.org\/10.1002\/mco2.70006","DOI":"10.1002\/mco2.70006"},{"key":"3084_CR34","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D (2021) Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA 325:669\u2013685. https:\/\/doi.org\/10.1001\/jama.2021.0106","journal-title":"JAMA"},{"key":"3084_CR35","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D (2021) Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther 221:107753. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107753","journal-title":"Pharmacol Ther"},{"key":"3084_CR36","doi-asserted-by":"publisher","first-page":"1212476","DOI":"10.3389\/fimmu.2023.1212476","volume":"14","author":"R Rui","year":"2023","unstructured":"Rui R, Zhou L, He S (2023) Cancer immunotherapies: advances and bottlenecks. Front Immunol 14:1212476. https:\/\/doi.org\/10.3389\/fimmu.2023.1212476","journal-title":"Front Immunol"},{"key":"3084_CR37","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/nrd.2018.102","volume":"17","author":"M Cully","year":"2018","unstructured":"Cully M (2018) Cancer: re-educating tumour-associated macrophages with nanoparticles. Nat Rev Drug Discov 17:468. https:\/\/doi.org\/10.1038\/nrd.2018.102","journal-title":"Nat Rev Drug Discov"},{"key":"3084_CR38","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","volume":"30","author":"M Lv","year":"2020","unstructured":"Lv M, Chen M, Zhang R, Zhang W, Wang C, Zhang Y et al (2020) Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy. Cell Res 30:966\u2013979. https:\/\/doi.org\/10.1038\/s41422-020-00395-4","journal-title":"Cell Res"},{"key":"3084_CR39","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1158\/0008-5472.Can-23-2390","volume":"84","author":"L Yan","year":"2024","unstructured":"Yan L, Wu M, Wang T, Yuan H, Zhang X, Zhang H et al (2024) Breast cancer stem cells secrete MIF to mediate tumor metabolic reprogramming that drives immune evasion. Cancer Res 84:1270\u20131285. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-2390","journal-title":"Cancer Res"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03084-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-026-03084-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03084-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:35:47Z","timestamp":1784997347000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-026-03084-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3084"],"URL":"https:\/\/doi.org\/10.1007\/s10147-026-03084-1","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving human participants was approved by the Ethics Committee of the Affiliated Tumor Hospital of Guangxi Medical University (KY20251006). The study was conducted in accordance with the declaration of Helsinki. The research was conducted in compliance with all applicable local regulations and institutional policies. Written informed consent was obtained from each participant prior to their inclusion in the study.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}